Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes

References

• BrockCOlesenSSOlesenAEFrøkjaerJBAndresenTDrewesAMOpioid-induced bowel dysfunction: pathophysiology and managementDrugs201272141847186522950533
   PubMed Web of Science ®Google Scholar
• BaderSJaroslawskiKBlumHEBeckerGOpioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromideClin Med Insights Oncol2011520121121836816
   PubMedGoogle Scholar
• BellTJPanchalSJMiaskowskiCBolgeSCMilanovaTWilliamsonRThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)Pain Med2009101354218721170
   PubMed Web of Science ®Google Scholar
• PanchalSJMüller-SchwefePWurzelmannJIOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInt J Clin Pract20076171181118717488292
   PubMed Web of Science ®Google Scholar
• MeuserTPietruckCRadbruchLStutePLehmannKAGrondSSymptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiologyPain200193324725711514084
   PubMed Web of Science ®Google Scholar
• SiemensWGaertnerJBeckerGAdvances in pharmacotherapy for opioid-induced constipation – a systematic reviewExpert Opin Pharmacother201516451553225539282
   PubMed Web of Science ®Google Scholar
• PoulsenJLBrockCOlesenAENilssonMDrewesAMClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionClin Exp Gastroenterol2014734535825278772
   PubMedGoogle Scholar
• BeckerGBlumHENovel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileusLancet200937396701198120619217656
   PubMed Web of Science ®Google Scholar
• CoyneKLoCasaleRDattoCSextonCYeomansKTackJOpioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart reviewClinicoecon Outcomes Res201424626928124904217
   PubMedGoogle Scholar
• HjalteFBerggrenABergendahlHHjortsbergCThe direct and indirect costs of opioid-induced constipationJ Pain Symptom Manage201040569670320727708
   PubMed Web of Science ®Google Scholar
• LeppertWEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionDrug Des Devel Ther2015922152231
   PubMed Web of Science ®Google Scholar
• FordACBrennerDMSchoenfeldPSEfficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysisAm J Gastroenterol2013108101566157423752879
   PubMed Web of Science ®Google Scholar
• European Medicines Agency Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000870/human_med_001022.jsp&mid=WC0b01ac058001d124Accessed October 28, 2015
   Google Scholar
• HolzerPOpioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humansNeurosci Lett20043611–319219515135926
   PubMed Web of Science ®Google Scholar
• KumarLBarkerCEmmanuelAOpioid-induced constipation: pathophysiology, clinical consequences, and managementGastroenterol Res Pract2014201414173724883055
   PubMed Web of Science ®Google Scholar
• BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician2008112 SupplS105S12018443635
   PubMed Web of Science ®Google Scholar
• GaertnerJSiemensWCamilleriMDefinitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic reviewJ Clin Gastroenterol201549191625356996
   PubMed Web of Science ®Google Scholar
• LongstrethGFThompsonWGCheyWDHoughtonLAMearinFSpillerRCFunctional bowel disordersGastroenterology200613051480149116678561
   PubMed Web of Science ®Google Scholar
• JoswickTMareyaSMLichtlenPWoldegeorgisFUenoRTime to onset of lubiprostone treatment effect in chronic non-cancer pain patients with opioid-induced constipation: Data from two phase 3, randomized, double-blind, placebo-controlled trialsGastroenterology20131445 Supplement 1540
   Google Scholar
• LichtlenPJoswickTWoldegeorgisFUenoRLubiprostone is well tolerated in chronic non-cancer pain patients with opioid-induced constipation in three phase 3, randomized, double-blind, placebo-controlled trialsGastroenterology20131445 Supplement 1916
   Google Scholar
• MareyaSMLichtlenPWoldegeorgisFJoswickTUenoRLubiprostone improves complete spontaneous bowel movement frequency in chronic non-cancer pain patients with opioid-induced constipationGastroenterology20131445 Supplement 1539540
   Web of Science ®Google Scholar
• WirzSNadstawekJElsenCJunkerUWartenbergHCLaxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactuloseEur J Cancer Care (Engl)201221113114021880080
   PubMed Web of Science ®Google Scholar
• IrvingGPenzesJRamjattanBA randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer painJ Pain201112217518421292168
   PubMed Web of Science ®Google Scholar
• JansenJPLorchDLanganJA randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer painJ Pain201112218519321292169
   PubMed Web of Science ®Google Scholar
• WirzSWittmannMSchenkMGastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphineEur J Pain200913773774318977159
   PubMed Web of Science ®Google Scholar
• PortenoyRKThomasJMoehlBMLSubcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging studyJ Pain Symptom Manage200835545846818440447
   PubMed Web of Science ®Google Scholar
• WirzSWartenbergHCNadstawekJLess nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer painSupport Care Cancer2008169999100918095008
   PubMed Web of Science ®Google Scholar
• PrichardDBharuchaAManagement of opioid-induced constipation for people in palliative careInt J Palliat Nurs201521627228026126675
   PubMedGoogle Scholar
• BaderSDürkTBeckerGMethylnaltrexone for the treatment of opioid-induced constipationExpert Rev Gastroenterol Hepatol201371132623265145
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug AdministrationFDA Approves Relistor for Opioid-Induced Constipation Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116885.htmAccessed January 15, 2016
   Google Scholar
• HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Available from: http://handbook.cochrane.org/Accessed October 28, 2013
   Google Scholar
• StovoldEBeecherDFoxleeRNoel-StorrAStudy flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagramSyst Rev201435424886533
   PubMedGoogle Scholar
• NalamachuSRPergolizziJTaylorREfficacy and tolerability of subcutaneous methylnaltrexone in patients with advanced illness and opioid-Induced constipation: a responder analysis of 2 randomized, placebo-controlled trialsPain Pract201515656457124815199
   PubMed Web of Science ®Google Scholar
• NeefjesECvan der VorstMJBoddaertMSClinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexoneBMC Palliat Care2014134225165428
   PubMed Web of Science ®Google Scholar
• ViscusiERBarrettACPatersonCForbesWPEfficacy and safety of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain: a placebo crossover analysisReg Anesth Pain Med201641939826650429
   PubMed Web of Science ®Google Scholar
• MichnaEBlonskyERSchulmanSSubcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled studyJ Pain201112555456221429809
   PubMed Web of Science ®Google Scholar
• RauckRLPeppinJIsraelROral methylnaltrexone for the treatment of opioid-induced constipation in patients with noncancer painGastroenterology2012142suppl 1160
   Google Scholar
• BullJWellmanCVIsraelRJBarrettACPatersonCForbesWPFixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extensionJ Palliat Med201518759360025973526
   PubMed Web of Science ®Google Scholar
• SlatkinNThomasJLipmanAGMethylnaltrexone for treatment of opioid-induced constipation in advanced illness patientsJ Support Oncol200971394619278178
   PubMedGoogle Scholar
• ThomasJKarverSCooneyGAMethylnaltrexone for opioid-induced constipation in advanced illnessN Engl J Med2008358222332234318509120
   PubMed Web of Science ®Google Scholar
• RauckRLPeppinJIsraelROral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-cancer painDigestive Disease Week (DDW)519–222012San Diego, CA Available from: http://www.medscape.com/viewcollection/32463Accessed October 28, 2015
   Google Scholar
• AnissianLSchwartzHWVincentKSubcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgeryJ Hosp Med201272677221998076
   PubMed Web of Science ®Google Scholar
• MackeyACGreenLGreenePAviganMMethylnaltrexone and gastrointestinal perforationJ Pain Symptom Manage2010401e1e320619194
   PubMedGoogle Scholar
• SantucciGBattistaVMethylnaltrexone for opioid-induced constipation in patients at the end of lifeInt J Palliat Nurs201521416216425901587
   PubMedGoogle Scholar
• CorsettiMTackJNaloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipationDrugs Today (Barc)201551847948926380386
   PubMed Web of Science ®Google Scholar
• BalshemHHelfandMSchünemannHJGrading of recommendations assessment, development and evaluation (short GRADE)J Clin Epidemiol201164440140621208779
   PubMed Web of Science ®Google Scholar